Standard Interpretations - Table of Contents
• Standard Number: 1910.1030

October 4, 2007

Mr. Paul Dufresne, R.Ph., MS
Pharmacy Manager
American Homecare Federation
31 Moody Street
Enfield, CT 06083

Dear Mr. Dufresne:

Thank you for your inquiry to the Occupational Safety and Health Administration. Your letter was forwarded to OSHA's Directorate of Enforcement Programs (DEP) for a response. This letter constitutes OSHA's interpretation only of the requirements discussed and may not be applicable to any scenarios or questions not delineated within your original inquiry. You had specific questions regarding the applicability of OSHA's bloodborne pathogens standard, 29 CFR 1910.1030 to the use of needles with self-infuse bleeding products. Your questions are restated below followed by OSHA's responses.

Scenario: A hemophilia home healthcare company supplies bleeding products to patients nationwide. Many patients with bleeding disorders self-infuse their products while other patients have professional nursing services provide in-home assistance with venipuncture and infusion.

Question 1: Does OSHA's bloodborne pathogens standard, 29 CFR 1910.1030, require that safety needles be sent to patients who self-infuse?

Reply 1: No. Your company is not required to send safety needles to persons who self-infuse bleeding products or who self-inject any other medication. The Occupational Safety and health Act of 1970 (OSH Act) only protects employees. 29 USC §653(a) states that the OSH Act applies to employment.

Question 2: Does OSHA's Bloodborne Pathogens Standard, 29 CFR 1910.1030, require us to provide safety needles when an outside party (e.g., home healthcare professional) uses our products to infuse a patient in his/her home?

Reply 2: The standard applies to employers having employees with occupational exposure to blood or other potentially infectious materials (OPIM). During a phone conversation with a